Related Experiment Video

Updated: Aug 16, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Propofol and thiopental for refractory status epilepticus in children

J P J van Gestel1, H J Blussé van Oud-Alblas, M Malingré

  • 1Pediatric Intensive Care Unit, University Medical Center Utrecht, Wilhelmina Children's Hospital, The Netherlands. j.vangestel@umcutrecht.nl

Neurology
|August 24, 2005
PubMed

Insights

Propofol is a safer and effective anesthetic for pediatric refractory status epilepticus (RSE). This study suggests using propofol before thiopental due to fewer side effects and comparable efficacy in treating RSE.

Area of Science:

  • Pediatric Neurology
  • Anesthesiology
  • Critical Care Medicine

Background:

  • Refractory status epilepticus (RSE) in children is a neurological emergency requiring prompt and effective treatment.
  • Traditional treatments like thiopental carry significant risks of serious adverse events.

Purpose of the Study:

  • To compare the safety and efficacy of propofol versus thiopental for managing pediatric RSE.
  • To evaluate the potential of propofol as a first-line agent in RSE treatment protocols.

Main Methods:

  • Retrospective review of 34 episodes of RSE in children.
  • Analysis of treatment protocols, efficacy, and adverse events associated with propofol and thiopental administration.

Main Results:

  • Thiopental was effective but associated with serious, often irreversible side effects.
  • Propofol, administered under a strict protocol, demonstrated high efficacy with infrequent, minor, and reversible side effects.
  • Propofol use obviated the need for thiopental in many cases.

Conclusions:

  • Propofol is a safer and effective alternative to thiopental for pediatric RSE.
  • The study recommends considering propofol as an earlier treatment option for RSE in children.

More Related Videos

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...